BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28797949)

  • 1. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).
    van Praag VM; Rueten-Budde AJ; Jeys LM; Laitinen MK; Pollock R; Aston W; van der Hage JA; Dijkstra PDS; Ferguson PC; Griffin AM; Willeumier JJ; Wunder JS; van de Sande MAJ; Fiocco M
    Eur J Cancer; 2017 Sep; 83():313-323. PubMed ID: 28797949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting.
    Hagenmaier HSF; van Beeck AGK; Haas RL; van Praag VM; van Bodegom-Vos L; van der Hage JA; Krol S; Speetjens FM; Cleven AHG; Navas A; Kroon HM; Moeri-Schimmel RG; Leyerzapf NAC; van de Sande MAJ
    Sarcoma; 2021; 2021():8851354. PubMed ID: 34720664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.
    Acem I; van Houdt WJ; Grünhagen DJ; van der Graaf WTA; Rueten-Budde AJ; Gelderblom H; Verhoef C; ; van de Sande MAJ
    Eur J Cancer; 2022 Apr; 165():71-80. PubMed ID: 35219025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
    Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
    Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
    J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma.
    Rueten-Budde AJ; van Praag VM; van de Sande MAJ; Fiocco M;
    J Surg Oncol; 2021 Mar; 123(4):1050-1056. PubMed ID: 33332599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extremity soft tissue sarcoma: does surgical margin impact survival?].
    Medrano-Guzmán R; Brener-Chaoul M; García-Ríos LE; Luna-Castillo M
    Cir Cir; 2023 Dec; 91(6):810-815. PubMed ID: 36423355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
    Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
    BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 2001 May; 8(4):278-89. PubMed ID: 11352300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.
    Willeumier J; Fiocco M; Nout R; Dijkstra S; Aston W; Pollock R; Hartgrink H; Bovée J; van de Sande M
    Int Orthop; 2015 May; 39(5):935-41. PubMed ID: 25743028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly.
    Bleckman RF; Acem I; van Praag VM; Dorleijn DMJ; Verhoef C; Schrage YM; Haas RML; van de Sande MAJ; The Collaborative Persarc Research Group ;
    Eur J Surg Oncol; 2022 May; 48(5):985-993. PubMed ID: 34930647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register.
    Tsagozis P; Bauer HC; Styring E; Trovik CS; Zaikova O; Brosjö O
    J Surg Oncol; 2015 Jun; 111(8):951-6. PubMed ID: 26040651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk.
    Biau DJ; Ferguson PC; Turcotte RE; Chung P; Isler MH; Riad S; Griffin AM; Catton CN; O'Sullivan B; Wunder JS
    J Clin Oncol; 2011 Oct; 29(30):4029-35. PubMed ID: 21931025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation.
    Cahlon O; Brennan MF; Jia X; Qin LX; Singer S; Alektiar KM
    Ann Surg; 2012 Feb; 255(2):343-7. PubMed ID: 22143203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.